Cancer immunotherapy: Potential new target found

Myeloid-derived suppressor cells (MDSCs), are found abundantly in the microenvironment around tumors. They interfere with immune response, promoting cancer progression. Now scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and shrink tumors in preclinical experiments.